文献速递颈动脉与弓上血管

既往无症状患者发生颈动脉相关卒中时的危险因素特征与解剖特征

Risk factor profile and anatomic features of previously asymptomatic patients presenting with carotid-related stroke.
PubMed 文献 · J Vasc Surg · 2018-05-24

回顾2005至2015年一家三级转诊中心3382例缺血性卒中患者,聚焦219例(7%)既往无症状、影像证实颈动脉狭窄≥50%且同侧梗死、病因判为颈动脉相关的卒中患者,分析其危险因素、解剖特征与结局;43%表现为同侧颈内动脉闭塞,同时接受抗血小板与降脂治疗者发生中重度卒中比例显著低于未联合治疗者(44% vs 78%,P=.006)。

要点

  • 既往无症状颈动脉相关卒中患者中43%以同侧颈内动脉闭塞为责任病变。
  • 同时接受抗血小板与降脂治疗者中重度卒中比例44% vs 未联合治疗者78%(P=.006)。
  • 接受适当风险降低药物治疗者仍存在颈动脉介导卒中的风险。

核心结论

  • 在既往无症状的颈动脉相关卒中患者中,43%的责任病变为颈内动脉闭塞。
  • 未接受抗血小板与降脂联合治疗的既往无症状患者发生颈动脉相关卒中时,更可能出现严重致残性卒中。
  • 接受适当风险降低药物治疗者仍面临颈动脉介导卒中的风险,作者认为单纯药物治疗对显著颈动脉狭窄患者可能不足以预防卒中。

研究设计与样本

  • 回顾性分析2005至2015年一家三级转诊中心收治的3382例缺血性卒中患者数据。
  • 纳入影像学证实梗死灶位于有记录的颈动脉狭窄≥50%同侧、且接诊神经内科团队判定卒中病因为颈动脉相关的患者,共219例(占全部卒中的7%)。
  • 排除既往短暂性脑缺血发作、任何颈动脉病变同侧既往梗死、既往颈动脉血运重建、颅内出血或恶性肿瘤的患者。

主要发现

  • 219例颈动脉卒中患者中61%为白人、66%为男性,平均年龄68±12岁。
  • 危险因素以高血压(79%)和吸烟(目前吸烟33%;既往吸烟29%)为主。
  • 入院时50%正在接受抗血小板治疗(阿司匹林n=92[41%];氯吡格雷n=9[4%];双联治疗n=11[5%]),55%正在接受降脂药物(他汀n=115[53%];其他n=6[2%]),77例(35%)同时接受抗血小板与降脂治疗。
  • 219例中156例(71%)入院时美国国立卫生研究院卒中量表评分≥5分(中重度卒中),54例(25%)接受溶栓治疗,96例(43%)表现为同侧颈内动脉闭塞,117例(53%)最终接受颈动脉血运重建,中位时间为4天。
  • 同时接受抗血小板与降脂治疗者发生中重度卒中的可能性显著低于未联合治疗者(44% vs 78%;P=.006)。

临床怎么用

  • 作者认为,对于显著颈动脉狭窄患者,单纯药物治疗可能不足以预防卒中。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although carotid atherosclerotic-mediated stroke remains a major cause of morbidity and mortality, some have suggested intervention in carotid stenosis should be limited to symptomatic patients given the advances in medical therapy. The present study was conducted to assess the atherosclerotic risk factor profiles, anatomic features, and clinical outcomes of previously asymptomatic patients admitted with stroke of carotid etiology. METHODS: We reviewed the data from 3382 patients admitted to a tertiary referral center with an ischemic stroke during 2005 to 2015. We focused on patients admitted with a radiographically confirmed infarct ipsilateral to a documented carotid artery stenosis ≥50%, with the admitting neurology team adjudicating the stroke etiology as carotid related. Patients were excluded if they had had a previous transient ischemic attack, previous infarct ipsilateral to any carotid lesion, or previous carotid revascularization, intracranial hemorrhage, or malignancy. Patient demographic data, medical treatments before stroke, stroke admission carotid imaging, and stroke treatments and outcomes were assessed. RESULTS: A total of 219 carotid stroke patients (7% of all strokes) were identified, of whom 61% were white and 66% were men, with a mean age of 68 ± 12 years. Hypertension (79%) and smoking (33% current; 29% former) were predominant risk factors. On admission, 50% were receiving antiplatelet therapy (aspirin, n = 92 [41%]; clopidogrel, n = 9 [4%]; dual therapy, n = 11 [5%]) and 55% were receiving lipid-lowering agents (statin, n = 115 [53%]; other, n = 6 [2%]); 77 patients (35%) were receiving both antiplatelet and lipid-lowering therapy. Of the 219 patients, 156 (71%) presented with a moderate or severe stroke (National Institutes of Health stroke scale ≥5 at admission), 54 (25%) received lytic therapy, 96 (43%) presented with an occluded ipsilateral internal carotid artery, and 117 (53%) ultimately underwent carotid revascularization at a median of 4 days. Individuals receiving both antiplatelet and lipid-lowering therapy were significantly less likely to experience a moderate or severe stroke (44% vs 78%; P = .006). CONCLUSIONS: Internal carotid artery occlusion is the culprit lesion in 43% of carotid-related strokes in those without previous symptoms. Previously asymptomatic patients not receiving combined antiplatelet and lipid-lowering medical therapy presenting with carotid-related stroke are significantly more likely to experience a severe, debilitating stroke. However, those receiving appropriate risk-reduction medical therapy are still at risk of carotid-mediated stroke. These results suggest medical therapy alone is unlikely to be sufficient stroke prevention for patients with significant carotid stenosis.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Klarin D, Cambria RP, Ergul EA, et al. Risk factor profile and anatomic features of previously asymptomatic patients presenting with carotid-related stroke. J Vasc Surg. 2018. PMID: 29804741. doi:10.1016/j.jvs.2018.01.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。